Ongoing Projects
Czech Science Foundation (GA ČR):
18-08169S - Study of individual topoisomerase ii isoforms in anticancer and cardiotoxic effects of anthracyclines and their modulations by bisdioxopiperazines (2018 - 2020)
19-14758Y - Novel photosensitizers for vascular targeted photodynamic therapy (2019-2021)
Past Projects
Charles University in Prague:
UNCE 204019/304019/2012 - Research Center for the Study of Toxic and Protective Effects of Drugs on Cardiovascular System (2012 – 2017)
Czech Science Foundation (GA ČR):
13-15008S - New potential cardioprotective agents: study of structure-activity relationships in various types of myocardial injury (2013 - 2017)
13-27761S - Development of new photosensitizers for photodynamic therapy and investigation of their mechanism of action on cellular
level (2013 - 2016)
GA305/09/0416 - Myocardial damage induced by anticancer drugs and ischemia-reperfusion: new possibilities of pharmacological cardioprotection (2009-2012)
GP305/05/P156 - Study of protective effects of novel iron chelators in the heart injury induced by oxidative stress and anthracycline cytostatics (2005-2007)
GA305/03/1511 – Cardiovascular, potentially cardioprotective and biotransformation effects of novel iron-chelating agents (2003-2005)
Grant Agency, Ministry of Health of the Czech Republic (IGA MZ ČR):
NT12403 – Pharmaceutical analysis, study of pharmacokinetics and biotransformation of novel thiosemicarbazone anticancer drugs (2011- 2013)
NT13457 – Anthracycline cardiotoxicity – new possibilities of pharmacological cardioprotection and risks of combination with biologically-targeted anticancer therapy (2012-2015)
Grant Agency of the Charles University in Prague (GA UK):
1916214 - Study of the novel phthalocyanine and azaphthalocyanine photosensitizers for photodynamic therapy of tumors on cellular and molecular level (2014-2016)
299511 - Synthesis and study of antiproliferative effects of novel aroylhydrazone iron chelators (2011-2013)
367911 - Study of cardioprotective effects of novel aroylhydrazone prochelators of iron that are activated by oxidative stress (2011 – 2013)
112409 - Cardiotoxicity of anthracycline drugs: Study of molecular mechanisms of dexrazoxane-afforded cardioprotection; synthesis and initial pharmacological evaluation of its novel analogues (2009-2011)
51308 - Study of the role of free intracellular iron in the pathophysiology of catecholamine cardiotoxicity and possibilities of pharmacological cardioprotection (2008-2010)
124307 - Development of new cardioprotective iron chelators – Synthesis, pharmacological and bioanalytical evaluation (2007-2009)
Czech Society of Cardiology:
Study of the role of apoptosis in the anthracycline-induced myocardial damage (2006-2008)